Optiver Holding’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
+652
New +$289K ﹤0.01% 816
2026
Q1
Sell
-21
Closed -$9.52K 2761
2025
Q4
$9.52K Buy
+21
New +$9.05K ﹤0.01% 1157
2025
Q2
Sell
-27
Closed -$13.1K 1643
2025
Q1
$13.1K Buy
+27
New +$12.6K ﹤0.01% 813
2024
Q2
Sell
-378
Closed -$158K 1019
2024
Q1
$158K Buy
+378
New +$160K ﹤0.01% 488
2022
Q4
Sell
-32
Closed -$9K 504
2022
Q3
$9K Buy
+32
New +$9.21K ﹤0.01% 354
2022
Q1
Sell
-58
Closed -$11K 882
2021
Q4
$11K Hold
58
﹤0.01% 695
2021
Q3
$11K Sell
58
-33
-36% -$6.44K ﹤0.01% 561
2021
Q2
$18K Buy
+91
New +$19K ﹤0.01% 377

Other funds holding VRTX

Optiver Holding's VRTX Position: Q2 2026 in Review

Optiver Holding opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 652 shares worth $324K. The stake represents ﹤0.01% of the portfolio and ranks #816 among its holdings. This is a return to the name: Optiver Holding previously reported a position in VRTX as recently as Q4 2025.

Optiver Holding first reported a position in VRTX in Q2 2021 and has held it in 8 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Optiver Holding held 652 shares of Vertex Pharmaceuticals worth $324K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #816 holding.
  • Optiver Holding first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.